Ipamorelin (10mg)
Ipamorelin is supplied strictly as a laboratory research material for analytical and scientific use only. Available to qualified researchers, laboratories, and institutions in Perth and across Western Australia, with Australian-based fulfilment.
Intended for in‑vitro research, assay development, method validation, and controlled scientific investigation by appropriately qualified professionals.
Product details
-
Product: Ipamorelin
-
Molecular Formula: C38H49N9O5
-
Strength / size: Ipamorelin 10 Mg
-
Category: Research compound / research peptide
-
Form: Lyophilised powder
-
Use: Laboratory research only
-
Supply: Perth & Western Australia (AU shipping)
|
SEQUENCE: Aib-His-D-2Nal-D-Phe-Lys-NH2
|
|
MOLECULAR WEIGHT: 711.86 g/mol
|
Ipamorelin is a small pentapeptide that binds to the receptor of ghrelin/growth hormone secretagogue (GHS), and is speculated to trigger the release of growth hormone via pituitary cells. Research has suggested the peptide to be selective in its mode of action. Ipamorelin, researchers report, does not appear to induce non-specific release of hormones like prolactin, thyroid-stimulating hormone, ACTH, luteinizing hormone, follicle-stimulating hormone, or cortisol.
The high specificity of the peptide makes it an ideal model for the study of selectivity in receptor binding. It appears to function through interaction with cognate receptors on the target cell surface and mediates a cellular response. Ipamorelin may induce secretions from the pituitary gland, promoting growth in animal study models. In addition, it may not only trigger the expression of insulin-like growth factor-1(IGF-1) but may also inhibit the secretion of somatostatin. IGF-1 is considered to be the main anabolic mediator of growth hormone.
